Laborie Completes Purchase of JADA Postpartum Hemorrhage System From Organon

Laborie Medical Technologies has completed its acquisition of the JADA System, a device for treating abnormal bleeding after childbirth, from Organon, both companies said on Wednesday, January 28. Organon said in its closing announcement that the sale had been completed and referred to its earlier announcement for the terms.

When the companies agreed to the deal on November 7, Organon said the transaction was valued at up to $465 million: $440 million to be paid at closing, subject to adjustments, and up to $25 million more if certain 2026 revenue targets are met, according to its November release. The total represents 6.5 times JADA's trailing 12-month revenue, Organon said.

Organon, a global health care company headquartered in Jersey City, New Jersey, said the net proceeds will go toward reducing debt. It had expected the deal to close in the first quarter of 2026.

The device and the team

JADA uses a low-level intrauterine vacuum to control and treat abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted, according to Organon. Laborie said the device uses the vacuum to trigger natural uterine contractions and called it an FDA-cleared device. The companies said JADA has been used to help more than 136,000 mothers in more than 20 countries.

Organon had said about 100 employees were expected to transfer to Laborie. In its own closing release, Laborie said it would welcome more than 90 new colleagues, mainly in commercial roles.

Organon bought JADA in June 2021 through its acquisition of Alydia Health, and JADA sales rose 40%, excluding currency effects, to $61 million in 2024, ROI-NJ reported, citing Fierce Biotech.

Laborie's obstetrics push

Laborie, based in Portsmouth, New Hampshire, makes diagnostic and therapeutic products in urology, urogynecology, gastroenterology, obstetrics, gynecology and neonatal health. It is owned by Patricia Industries, part of Investor AB.

"The JADA System helps care teams provide treatment during one of the most vulnerable moments of childbirth when every second counts," said Nikki Bruce, Laborie's vice president and general manager of obstetrics.

Chris Smith, Laborie's president and chief executive, called the deal "a tremendous milestone for our OB business and an exciting chapter in Laborie's history."

Yuriy Prilutskiy, co-head of Patricia Industries, said the transaction reflects the owner's commitment to "growing our platform companies through acquisitions."

Goldman Sachs acted as financial adviser to Organon, according to its November release.